Screen Therapeutics LLC has formed a partnership with Immunaccel to focus on the discovery and development of next generation cancer immunotherapies. Screen Therapeutics will combine its immunology expertise, capabilities and know-how with Immunaccel's IP, know-how and proprietary cell lines to discover next-generation cancer therapies targeting stromal interactions in the tumor...